December 01, 2025

Reaching Everyone, Everywhere: Breaking Barriers in Hepatitis C Testing

As global funding declines, decentralized testing, telehealth, and community-based care are helping expand access to HCV diagnosis and treatment

The Pathologist

December 01, 2025

WHO Issues Conditional GLP-1 Obesity Guidelines

New recommendations emphasize equity barriers, health-system readiness, and the need for integrated chronic-disease management.

Conexiant

November 25, 2025

AGA unveils new clinical practice guideline for Crohn's disease

Of the 16 recommendations, the panel rated one as “strong,” nine as “conditional,” and six as “knowledge gaps.”

Conexiant

November 24, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

November 13, 2025

Final Overall Survival Confirms Benefit of Durvalumab Plus FLOT in Resectable Gastric and Gastroesophageal Junction Adenocarcinomas

The addition of the PD-L1–targeting monoclonal antibody durvalumab to conventional perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a statistical...

The ASCO Post

November 06, 2025

AGA issues updated guidance on HDV management

An AGA panel recommended universal HDV screening for all patients with chronic HBV infection.

Conexiant

November 04, 2025

New Poll: Only 1 in 3 Link Alcohol to Cancer

“Individuals who drink alcohol were more likely to believe that alcohol consumption has no effect on cancer risk, which is alarming, given the growing burden of alcohol-related cancers in the United States."

Conexiant

October 21, 2025

Localized PI3K-Altered Colorectal Cancer: Does Low-Dose Aspirin Reduce the Risk of Recurrence?

In a Scandinavian trial (ALASCCA) reported in the New England Journal of Medicine, Martling et al found that low-dose aspirin reduced the risk of disease recurrence vs placebo in patients with PI3K-al...

The ASCO Post

October 10, 2025

DiLumen: Expanding the Boundaries of Endoluminal Therapy

The DiLumen Platform of products give advanced endoscopists an additional tool like no other. These devices enhance the ability to perform more efficiently during colonic procedures.

Lumendi